UnitedHealth Group (NYSE:UNH) Stock Rating Reaffirmed by Truist Financial

UnitedHealth Group (NYSE:UNH)‘s stock had its “buy” rating reiterated by equities researchers at Truist Financial in a research report issued to clients and investors on Wednesday, Benzinga reports. They presently have a $625.00 price objective on the healthcare conglomerate’s stock, down from their previous price objective of $640.00. Truist Financial’s price objective would suggest a potential upside of 10.42% from the company’s previous close.

Several other equities research analysts have also recently issued reports on UNH. Bank of America decreased their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and upped their price objective for the stock from $481.00 to $647.00 in a report on Wednesday, July 17th. Morgan Stanley lowered their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday. Stephens reduced their price objective on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research note on Wednesday. Finally, Wells Fargo & Company lifted their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Two investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $615.16.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $566.00 on Wednesday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. The stock has a market capitalization of $522.66 billion, a P/E ratio of 37.53, a P/E/G ratio of 1.69 and a beta of 0.58. The firm’s 50-day moving average is $584.20 and its two-hundred day moving average is $533.07. UnitedHealth Group has a 12-month low of $436.38 and a 12-month high of $608.63.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.56 EPS. Equities analysts predict that UnitedHealth Group will post 27.68 earnings per share for the current year.

Institutional Trading of UnitedHealth Group

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Kathleen S. Wright Associates Inc. acquired a new stake in shares of UnitedHealth Group in the 3rd quarter valued at about $27,000. Global Wealth Strategies & Associates raised its stake in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares in the last quarter. Macroview Investment Management LLC grew its position in shares of UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares in the last quarter. West Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter valued at approximately $32,000. Finally, Delos Wealth Advisors LLC boosted its holdings in UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.